Ist, CGS21680 and ATL193, can effectively suppress inflammation [10,11]. Activation of A2AR leads to attenuation of glomerulonephritis and renal injury [12,13,14]. Further, recent studies identified that A2AR activation inhibits Rho/ROCK1 in hepatic stellate cells [15]. All of the above strongly suggest that A2AR manipulation plays an important regulatory role in inflammation and may also affect EMT event. Therefore, we hypothesize that activation of A2AR may suppress cellular 
infiltration, EMT event and profibrogenic factors, thereby preventing consequent pathology of RIF. Conversely, inactivation of A2AR may lead exacerbation of RIF. A unilateral ureteral obstruction (UUO) model has been refined to elucidate the pathogenesis and mechanisms responsible for RIF [16,17]. It has been shown that the infiltration of macrophages and T cells and lymphocyte dysfunction are two major mechanAdenosine A2AR and Renal Interstitial FibrosisTable 1. Experimental groups.kidneys were harvested for the following imunohistochemistry evaluations.UUO 2 + + 2 + + CGS 2 2 + 2 2 +group WT+Sham WT+UUO+Veh WT+UUO+CGS KO+Sham KO+UUO+Veh KO+UUO+CGSA2AR + + + 2 2Unilateral ureteral obstruction (UUO) modelMice (20?5 g weight) were subjected to the UUO procedure under anesthesia as previously described [22] with modifications. All surgical procedures were performed under an operating microscope. Briefly, mice were first anesthetized with sodium pentobarbital (50 mg/kg, i.p.). After a left flank incision was taken, the left ureter was exposed, ligated with 6? silk sutures at two points, and cut between the two ligatures. Lastly, the peritoneal membrane and skin were sutured. Sham surgery was performed as control by following all steps of UUO-procedure except ligation and cut of ureter.doi:10.1371/journal.pone.0060173.tisms contributing to the UUO-induced RIF model [18,19]. In this model, at the cellular level, tubular dilatation leads the tubular epithelia to lose their epithelial characteristics and acquire mesenchymal traits such as a-SMA expression and actin reorganization. At molecular level, TGF-b1 plays a key role in EMT via activation of its downstream Rho/ROCK signaling pathway [20]. Using the experimental UUO-induced RIF mouse model, the present study was aimed to evaluate the modulatory effect of A2AR-based manipulation on several aspects of RIF progression, including interstitial lymphocyte infiltration, cellular biomarkers of EMT, expression of the profibrogenic factor TGF-b1 and its downstream Rho/ROCK1 pathway, as well as the consequent extracellular matrix accumulation.Drug treatmentPharmacological activation of A2AR was induced by daily systemic administration of the selective A2AR agonist, CGS 21680 (Tocris, Cat# 1063, 0.4 mg/kg i.p.) from day 1 after UUO through the designed experimental time-points, i.e., day 3, 7, and 14 after UUO, when mice were scarified and their kidneys were harvested.Reverse transcription quantitative real-time PCR (RTqPCR)Total RNA extraction of renal sample was conducted using a total RNA extraction kit (BioFlux, Cat# BSC52S1) and the reverse transcription reaction was performed using SYBR Premix Ex Taq kit (13655-52-2 cost DRR041A, Dalian, China), according to the manufacturer’s instructions. Then qPCR was performed to AKT inhibitor 2 site quantify the expression level of A2AR, TGF-b1, and ROCK1 mRNAs using SYBR Premix Ex Taq kit (DRR041A, Dalian, China) and a qPCR reaction thermal cycle of 40 cycles of 95uC (30 s), 58uC (30 s), and 70uC (30 s). The 
glycerald.Ist, CGS21680 and ATL193, can effectively suppress inflammation [10,11]. Activation of A2AR leads to attenuation of glomerulonephritis and renal injury [12,13,14]. Further, recent studies identified that A2AR activation inhibits Rho/ROCK1 in hepatic stellate cells [15]. All of the above strongly suggest that A2AR manipulation plays an important regulatory role in inflammation and may also affect EMT event. Therefore, we hypothesize that activation of A2AR may suppress cellular infiltration, EMT event and profibrogenic factors, thereby preventing consequent pathology of RIF. Conversely, inactivation of A2AR may lead exacerbation of RIF. A unilateral ureteral obstruction (UUO) model has been refined to elucidate the pathogenesis and mechanisms responsible for RIF [16,17]. It has been shown that the infiltration of macrophages and T cells and lymphocyte dysfunction are two major mechanAdenosine A2AR and Renal Interstitial FibrosisTable 1. Experimental groups.kidneys were harvested for the following imunohistochemistry evaluations.UUO 2 + + 2 + + CGS 2 2 + 2 2 +group WT+Sham WT+UUO+Veh WT+UUO+CGS KO+Sham KO+UUO+Veh KO+UUO+CGSA2AR + + + 2 2Unilateral ureteral obstruction (UUO) modelMice (20?5 g weight) were subjected to the UUO procedure under anesthesia as previously described [22] with modifications. All surgical procedures were performed under an operating microscope. Briefly, mice were first anesthetized with sodium pentobarbital (50 mg/kg, i.p.). After a left flank incision was taken, the left ureter was exposed, ligated with 6? silk sutures at two points, and cut between the two ligatures. Lastly, the peritoneal membrane and skin were sutured. Sham surgery was performed as control by following all steps of UUO-procedure except ligation and cut of ureter.doi:10.1371/journal.pone.0060173.tisms contributing to the UUO-induced RIF model [18,19]. In this model, at the cellular level, tubular dilatation leads the tubular epithelia to lose their epithelial characteristics and acquire mesenchymal traits such as a-SMA expression and actin reorganization. At molecular level, TGF-b1 plays a key role in EMT via activation of its downstream Rho/ROCK signaling pathway [20]. Using the experimental UUO-induced RIF mouse model, the present study was aimed to evaluate the modulatory effect of A2AR-based manipulation on several aspects of RIF progression, including interstitial lymphocyte infiltration, cellular biomarkers of EMT, expression of the profibrogenic factor TGF-b1 and its downstream Rho/ROCK1 pathway, as well as the consequent extracellular matrix accumulation.Drug treatmentPharmacological activation of A2AR was induced by daily systemic administration of the selective A2AR agonist, CGS 21680 (Tocris, Cat# 1063, 0.4 mg/kg i.p.) from day 1 after UUO through the designed experimental time-points, i.e., day 3, 7, and 14 after UUO, when mice were scarified and their kidneys were harvested.Reverse transcription quantitative real-time PCR (RTqPCR)Total RNA extraction of renal sample was conducted using a total RNA extraction kit (BioFlux, Cat# BSC52S1) and the reverse transcription reaction was performed using SYBR Premix Ex Taq kit (DRR041A, Dalian, China), according to the manufacturer’s instructions. Then qPCR was performed to quantify the expression level of A2AR, TGF-b1, and ROCK1 mRNAs using SYBR Premix Ex Taq kit (DRR041A, Dalian, China) and a qPCR reaction thermal cycle of 40 cycles of 95uC (30 s), 58uC (30 s), and 70uC (30 s). The glycerald.
